Bravida (BRAV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
Net sales for Q4 2025 decreased by 2% year-over-year to SEK 7,913 million, with organic growth at -3%, acquisition growth at +3%, and FX impact at -2%.
EBITA margin improved to 8.1% in Q4 (from 7.5%), driven by strong performance in Denmark and Norway.
EPS increased 17% in Q4 and 16% for the full year.
Cash flow from operating activities was robust in Q4 at SEK 1,161 million, with cash conversion at 79% for the year.
Board proposes a dividend of SEK 3.80 per share, representing 63% of EPS.
Financial highlights
Q4 2025 net sales: SEK 7,913m, down from SEK 8,108m in Q4 2024.
Q4 2025 EBITA: SEK 641m, up from SEK 604m in Q4 2024.
Full-year EBITA margin improved to 5.9% from 5.2% in 2024.
Order intake rose 11% in Q4 and 5% for the full year; order backlog up 3% year-over-year to SEK 15,325 million.
Net debt/EBITDA at 1.1x at year-end.
Outlook and guidance
Management expects continued margin improvement, especially in Denmark and Norway, with slow demand recovery anticipated in 2026.
External forecasts predict 4% annual installation growth and stable service demand in 2026-2027.
Organic growth is not expected before late Q2 2026; stepwise recovery anticipated in the second half.
M&A activity expected to accelerate in 2026, returning to historical levels.
Price pressure expected to persist until demand increases.
Latest events from Bravida
- EBITA down 17% on flat sales, but cash flow and service growth offset installation weakness.BRAV
Q3 202418 Feb 2026 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 202418 Feb 2026 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 20243 Feb 2026 - EBITA margin rose to 4.5% as profit grew despite lower sales and market uncertainty.BRAV
Q1 202517 Nov 2025 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 202513 Nov 2025 - EBITA margin rose to 5.3% and EPS increased 24% despite lower sales and challenging markets.BRAV
Q3 202524 Oct 2025